September 2022 FDA Recall Pyridostigmine Bromide by Vistapharm, Inc.
D-0018-2023 - cGMP Deviations

This Class II drug recall was voluntarily initiated by Vistapharm, Inc. on September 30, 2022 for the product Pyridostigmine Bromide. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0018-2023

Reason for Recall
cGMP Deviations: Out of specification for assay of one of the preservative ingredients.
Initiated
09-30-2022
Reported
11-02-2022
Quantity
1980 cups

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC 66689-406-01

Batch or Lot Expiration Information

Lot# : 832400, Exp 08/2023